Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication

BACKGROUND: Predictors of adverse events (AE) associated with nevirapine use are needed to better understand reports of severe rash or liver enzyme elevation (LEE) in HIV+ women. METHODOLOGY: AE rates following ART initiation were retrospectively assessed in a multi-site cohort of 612 women. Predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Aaron, Erika, Kempf, Mirjam-Colette, Criniti, Shannon, Tedaldi, Ellen, Gracely, Ed, Warriner, Amy, Kumar, Ritu, Bachmann, Laura H.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935387/
https://www.ncbi.nlm.nih.gov/pubmed/20838641
http://dx.doi.org/10.1371/journal.pone.0012617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935387/
https://www.ncbi.nlm.nih.gov/pubmed/20838641
http://dx.doi.org/10.1371/journal.pone.0012617

Ejemplares similares